John Hancock Financial Opportunities Fund (NYSE:BTO – Get Free Report) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totaling 7,757 shares, an increase of 102.1% from the September 15th total of 3,838 shares. Based on an average trading volume of 43,673 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the company’s shares are short sold.
John Hancock Financial Opportunities Fund Trading Down 0.9%
Shares of BTO traded down $0.31 during trading hours on Wednesday, hitting $35.88. 10,215 shares of the stock traded hands, compared to its average volume of 47,553. The business has a fifty day moving average of $38.62 and a 200-day moving average of $38.08. John Hancock Financial Opportunities Fund has a 1-year low of $32.01 and a 1-year high of $42.00.
John Hancock Financial Opportunities Fund Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Friday, September 11th were given a $0.65 dividend. This represents a $2.60 dividend on an annualized basis and a yield of 7.2%. The ex-dividend date was Friday, September 11th.
Institutional Inflows and Outflows
John Hancock Financial Opportunities Fund Company Profile
John Hancock Financial Opportunities Fund is a publicly traded closed-end investment company listed on the New York Stock Exchange under the symbol BTO. The fund is designed to provide investors with exposure to the financial services sector rather than operating as a traditional financial services company.
The fund seeks a high level of current income and long-term capital appreciation by investing primarily in companies involved in banking, insurance, asset management, financial technology and other financial-related activities.
See Also
- Five stocks we like better than John Hancock Financial Opportunities Fund
- Birkenstock’s Strong Growth Creates a Buying Opportunity
- High Voltage Returns: Navitas Rewires AI Data Centers
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
- Albertsons Is Betting on a Turnaround—But Will It Pay Off?
Receive News & Ratings for John Hancock Financial Opportunities Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Hancock Financial Opportunities Fund and related companies with MarketBeat.com's FREE daily email newsletter.
